lebrikizumab
eli lilly
['adhere trial', 'lebri,(-celebri)', 'derm']
adhere trial on efficacy and safety of lebrikizumab in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis, from jama dermatology, free to read online during #aad2023 
JAMA #Dermatology publishes information concerning the skin, its diseases, and their treatment. #skincare